AHRMM Comment Letter to FDA RE: “Modernizing FDA’s Data Strategy”

By AHRMM

In September 2019, FDA announced its Technology Modernization Action Plan (TMAP)

The TMAP describes important near-term actions that FDA is taking to modernize use of technology—computer hardware, software, data and analytics—to advance FDA’s public health mission. The TMAP will provide a foundation for developing a more fluid, agile, and efficient FDA that is scaled to respond to novel technologies and a rapidly increasing workload.

To achieve these goals, FDA will need an Agency-wide, strategic approach not only to technology, but to data itself. Data is at the heart of FDA’s work as a science-based Agency, and FDA anticipates ongoing, rapid increases in the amount and complexity of the data that informs FDA’s regulatory decision-making and public health mission.

The FDA held a public meeting focused on possible Agency level approaches to data quality, data stewardship, data exchange and data analytics and asked for electronic or written comments to the public docket by July 30, 2020.

AHRMM sponsors the Learning Unique Device Identifier (UDI) Community (LUC). The LUC is comprised of physicians, clinicians, hospital supply chain professionals, manufacturers, distributors, software application providers, health care consultants and representatives from Group Purchasing Organizations (GPOs), GS1, HIBCC, HIDA and the FDA. The mission of the LUC is to enhance patient safety and improve supply chain efficiency by developing recommended practices that speed the adoption and maximize the utilization of the UDI.  

To date, there have been 13 LUC workgroups involving over 600 individuals that have addressed a wide range of issues from making the business case for UDI to incorporating the UDI throughout the recall process.

AHRMM submitted comments and recommendations in July 2020 to the FDA that were the results of the learnings and experiences of these multi-disciplinary workgroups.

 

Read the AHRMM Letter

Related Resources

On-Demand Educational Webinars
Management of inventory turns, reducing waste due to product expiration, and reducing annual audit shortfalls are all possible thanks to the UDI…
Podcasts
In this informational session, Karen Conway discusses her research with the FDA on value and the UDI.
On-Demand Educational Webinars
Management of inventory turns, reducing waste due to product expiration, and reducing inventory reconciliation adjustments are all possible thanks to…
Webcast
In this short video, explore what UDI is, why you should capture UDI through barcode scanning, and how to unlock the many benefits of UDI.
Toolkits/Methodology
AHRMM has compiled a list of health care organizations utilizing the UDI or planning to implement UDI adoption within the next 12 months.
Guides/Reports
This downloadable report reviews the recommended practices related to the allocation of multiple unique device indicators (UDI-DI).